Rhode Island 2025 Regular Session

Rhode Island House Bill H5173

Introduced
1/24/25  

Caption

Requires health plans that provide prescription benefits to cover at least one type of glucagon auto-injector, nasal spray, or formulation that does not require reconstitution to treat hypoglycemia. No copayment or deductible would be required.

Companion Bills

No companion bills found.

Previously Filed As

RI H5628

Mandates all health insurance contracts, plans, or policies provide the same reimbursement to independent healthcare facilities as that of hospital affiliated facilities where the same healthcare service is provided.

RI S0051

Limits copays, coinsurance or office deductibles for services of a physical therapist to the amount authorized for the services of a primary care physician or osteopath on or after January 1, 2026.

RI H5082

Limits copays, coinsurance or office deductibles for services of a physical therapist to the amount authorized for the services of a primary care physician or osteopath on or after January 1, 2026.

RI H6158

Mandates insurance coverage for scalp cooling treatments for breast cancer patients undergoing chemotherapy to prevent hair loss during chemotherapy treatments.

RI H6118

Requires coverage for acute mental health crisis mobile response and stabilization services to eligible individuals enrolled as plan beneficiaries.

RI S0263

Requires coverage for acute mental health crisis mobile response and stabilization services to eligible individuals enrolled as plan beneficiaries.

RI S0115

Requires health plans that provide prescription benefits to cover at least one type of glucagon auto-injector, nasal spray, or formulation that does not require reconstitution to treat hypoglycemia. No copayment or deductible would be required.

RI S0197

Prohibits an insurance company from imposing any cost-sharing requirements for any diagnostic or supplemental breast examinations.

Similar Bills

RI S0115

Requires health plans that provide prescription benefits to cover at least one type of glucagon auto-injector, nasal spray, or formulation that does not require reconstitution to treat hypoglycemia. No copayment or deductible would be required.

UT SB0146

Glucagon Amendments

MA H671

Relative to undesignated glucagon rescue therapies in schools

NJ A1882

Concerns administration of ready-to-use undesignated glucagon rescue therapy in public schools.

FL H0597

Diabetes Management in Schools

TX SB204

Relating to insurance coverage for certain devices used in the treatment of diabetes.

WV SB92

Glucagon for Schools Act

KY HB75

AN ACT relating to undesignated glucagon.